| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| iopromide 769 mg (iodine 370 mg)/mL injection, 75 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iopromide 769 mg (iodine 370 mg)/mL injection, 100 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iopromide 769 mg (iodine 370 mg)/mL injection, 200 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sodium nitroprusside 50 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 1.65 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 3.3 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iopromide 499 mg (iodine 240 mg)/mL injection, 50 mL bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| meningococcal group B heparin binding antigen fusion protein 50 microgram/0.5 mL + meningococcal group B adhesin A protein 50 microgram/0.5 mL + meningococcal group B factor H binding protein fusion protein 50 microgram/0.5 mL + meningococcal group B outer membrane vesicles 25 microgram/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| peginterferon beta-1a 125 microgram/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| peginterferon beta-1a 125 microgram / 0.5 mL injection, 0.5 mL pen device (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| rituximab 1.4 g/11.7 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| sildenafil 10 mg/12.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| tranexamic acid 500 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| alteplase 2 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| fondaparinux sodium 7.5 mg/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| fondaparinux sodium 10 mg/0.8 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| peginterferon beta-1a 63 microgram/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| peginterferon beta-1a 94 microgram/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| belatacept 250 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| gemcitabine 200 mg/5.26 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Gemcitabine (Kabi) 2 g/52.6 mL injection, 52.6 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| diphtheria toxoid vaccine 2 units/0.5 mL + tetanus toxoid vaccine 20 units/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| peginterferon beta-1a 63 microgram / 0.5 mL injection, 0.5 mL pen device (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| peginterferon beta-1a 94 microgram/0.5 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| magnesium sulfate heptahydrate 2.47 g/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| diphtheria toxoid vaccine 2 Lf / 0.5 mL + tetanus toxoid vaccine 2 Lf / 0.5 mL injection, 0.5 mL vial (medicinal product unit of use) |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| influenza virus quadrivalent vaccine 2015 injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| trastuzumab 600 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| aflibercept 4 mg/0.1 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| aflibercept 4 mg/0.1 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| meningococcal group A (Neisseria meningitidis) conjugate vaccine 5 microgram + meningococcal group C (Neisseria meningitidis) conjugate vaccine 5 microgram + meningococcal group W135 (Neisseria meningitidis) conjugate vaccine 5 microgram + meningococcal group Y (Neisseria meningitidis) conjugate vaccine 5 microgram injection, vial (medicinal product unit of use) |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| paclitaxel 100 mg/16.67 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| posaconazole 300 mg/16.7 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pembrolizumab 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| micafungin 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| micafungin 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| measles virus (Enders' attenuated Edmonston) live vaccine 1000 TCID50 units + mumps virus (Jeryl Lynn B level) live vaccine 12 500 TCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 TCID50 units injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| morphine hydrochloride trihydrate 20 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| morphine hydrochloride trihydrate 100 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| morphine hydrochloride trihydrate 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| morphine hydrochloride trihydrate 50 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| secukinumab 150 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| tranexamic acid 2 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| glatiramer acetate 40 mg / 1 mL injection, 1 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vedolizumab 300 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza trivalent adult vaccine 2015 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza trivalent child vaccine 2015 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza quadrivalent adult vaccine 2015 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| influenza quadrivalent child vaccine 2015 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| fosaprepitant 150 mg injection, 150 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vinflunine 50 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vinflunine 250 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 150 units (10.92 microgram) + lutropin alfa 75 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| secukinumab 150 mg/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nonacog gamma 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nonacog gamma 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nonacog gamma 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nonacog gamma 1000 international units injection, 1000 international units vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| nonacog gamma 3000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| meningococcal group A conjugate vaccine 10 microgram injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| meningococcal group C conjugate vaccine 5 microgram + meningococcal group W135 conjugate vaccine 5 microgram + meningococcal group Y (Neisseria meningitidis) conjugate vaccine 5 microgram injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| meningococcal group C conjugate vaccine 5 microgram + meningococcal group W135 conjugate vaccine 5 microgram + meningococcal group Y (Neisseria meningitidis) conjugate vaccine 5 microgram injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| Haemophilus influenzae type B polyribose ribitol phosphate vaccine 10 microgram injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 40 g/400 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lixisenatide 20 microgram/dose injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| lixisenatide 10 microgram/dose injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| insulin glargine 300 units/mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ketamine 200 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| botulinum toxin type A 100 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| botulinum toxin type A 200 mouse LD50 units injection, 200 mouse LD50 units vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| clostridium botulinum type A toxin-haemagglutinin complex 500 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| clostridium botulinum type A toxin-haemagglutinin complex 300 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| interferon alfa-2b 18 million units (69.231 microgram)/1.2 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| interferon alfa-2b 60 million units (230.769 microgram)/1.2 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| interferon alfa-2b 30 million units (115.385 microgram)/1.2 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 300 units (21.84 microgram)/0.5 mL injection, cartridge |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| metoprolol tartrate 5 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| somatropin 5 mg/1.5 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| somatropin 15 mg/1.5 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| somatropin 10 mg/1.5 mL injection |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) 500 microgram/0.3 mL injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) 150 microgram/0.3 mL injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| adrenaline (epinephrine) 300 microgram/0.3 mL injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| exenatide 5 microgram/dose injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| Epipen Auto-Injector 300 microgram/0.3 mL injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| exenatide 10 microgram/dose injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| Epipen Jr Auto-Injector 150 microgram/0.3 mL injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| teriparatide 20 microgram/dose injection, dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| choriogonadotropin alfa 250 microgram / 0.5 mL injection, dose (medicinal product unit of use) |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| triptorelin acetate 100 microgram/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dulaglutide 1.5 mg/0.5 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| adalimumab 40 mg/0.8 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| elosulfase alfa 5 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| zoledronic acid 5 mg/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ramucirumab 100 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| fondaparinux sodium 5 mg/0.4 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| zoledronic acid 4 mg/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| taliglucerase alfa 200 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| bortezomib 3 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 75 units (5.5 microgram)/0.125 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| follitropin alfa 450 units (33 microgram)/0.75 mL injection, pen device |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|